Corcept Therapeutics Inc (CORT)
22.21
-0.27
(-1.20%)
USD |
NASDAQ |
Apr 25, 16:00
22.50
+0.29
(+1.31%)
After-Hours: 20:00
Corcept Therapeutics Market Cap: 2.299B for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 2.327B |
| April 23, 2024 | 2.381B |
| April 22, 2024 | 2.308B |
| April 19, 2024 | 2.376B |
| April 18, 2024 | 2.346B |
| April 17, 2024 | 2.381B |
| April 16, 2024 | 2.421B |
| April 15, 2024 | 2.396B |
| April 12, 2024 | 2.434B |
| April 11, 2024 | 2.466B |
| April 10, 2024 | 2.464B |
| April 09, 2024 | 2.636B |
| April 08, 2024 | 2.508B |
| April 05, 2024 | 2.609B |
| April 04, 2024 | 2.593B |
| April 03, 2024 | 2.655B |
| April 02, 2024 | 2.625B |
| April 01, 2024 | 2.665B |
| March 28, 2024 | 2.608B |
| March 27, 2024 | 2.621B |
| March 26, 2024 | 2.562B |
| March 25, 2024 | 2.553B |
| March 22, 2024 | 2.536B |
| March 21, 2024 | 2.562B |
| March 20, 2024 | 2.527B |
| Date | Value |
|---|---|
| March 19, 2024 | 2.510B |
| March 18, 2024 | 2.517B |
| March 15, 2024 | 2.405B |
| March 14, 2024 | 2.450B |
| March 13, 2024 | 2.505B |
| March 12, 2024 | 2.532B |
| March 11, 2024 | 2.459B |
| March 08, 2024 | 2.447B |
| March 07, 2024 | 2.420B |
| March 06, 2024 | 2.384B |
| March 05, 2024 | 2.400B |
| March 04, 2024 | 2.500B |
| March 01, 2024 | 2.491B |
| February 29, 2024 | 2.433B |
| February 28, 2024 | 2.453B |
| February 27, 2024 | 2.500B |
| February 26, 2024 | 2.394B |
| February 23, 2024 | 2.324B |
| February 22, 2024 | 2.380B |
| February 21, 2024 | 2.242B |
| February 20, 2024 | 2.337B |
| February 16, 2024 | 2.351B |
| February 15, 2024 | 2.532B |
| February 14, 2024 | 2.505B |
| February 13, 2024 | 2.386B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.123B
Minimum
May 31 2019
3.567B
Maximum
Feb 08 2021
2.271B
Average
2.359B
Median
Aug 16 2021
Market Cap Benchmarks
| Ultragenyx Pharmaceutical Inc | 3.610B |
| Alnylam Pharmaceuticals Inc | 18.10B |
| Catalyst Pharmaceuticals Inc | 1.731B |
| United Therapeutics Corp | 11.11B |
| XOMA Corp | 307.39M |
Market Cap Related Metrics
| PE Ratio | 23.38 |
| PS Ratio | 5.144 |
| PEG Ratio | 2.939 |
| Price to Book Value | 4.537 |
| Price to Free Cash Flow | 19.55 |
| Price | 22.21 |
| Earnings Yield | 4.28% |
| PEGY Ratio | 2.939 |
| Operating PE Ratio | 23.13 |
| Normalized PE Ratio | 23.38 |